Press release
US Cancer Biomarkers Market to Surpass USD 11.2 Billion by 2030, Driven by Liquid Biopsies and AI-Enabled Diagnostics
The United States cancer biomarkers market, valued at USD 7.62 billion in 2025, is projected to reach USD 11.23 billion by 2030, registering a CAGR of 8.06%, according to DataM Intelligence. Market expansion is primarily driven by rising cancer prevalence, growing precision medicine adoption, and increased government support through initiatives such as the Cancer Moonshot program. Enhanced reimbursement mechanisms under CMS's Transitional Coverage and streamlined regulatory pathways from the FDA's Laboratory Developed Test (LDT) rule are encouraging rapid commercialization and uptake of diagnostic innovations across the country.Breast cancer dominates with 36.33% market share, while prostate cancer is projected to grow fast at 9.02% CAGR through 2030. On the technology front, protein biomarkers maintain leadership with over 50% contribution, while genetic biomarkers are emerging as the fastest-growing category, supported by advancements in multi-omic profiling and liquid biopsy adoption. The Sun Belt states-namely Texas, Florida, and Arizona-exhibit stronger demand growth, driven by their aging populations and improved state-level coverage mandates for biomarker testing.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/cancer-biomarkers-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ United States cancer biomarkers market projected to grow from USD 7.62 billion in 2025 to USD 11.23 billion by 2030 at an 8.06% CAGR.
➤ Breast cancer leads the disease segmentation; prostate biomarkers expected to grow fastest.
➤ Protein biomarkers dominate revenue while genetic biomarkers grow rapidly with falling sequencing costs.
➤ Omics technologies lead profiling, while immunoassays gain traction in mid-tier hospital settings.
➤ Federal Cancer Moonshot funding boosts R&D in minimally invasive detection and early diagnosis.
➤ Clinical laboratories show strongest growth due to centralized genomic analysis and cost efficiencies.
Market Segmentation
By disease type, breast cancer accounts for the largest market share due to widespread use of HER2, ER, and multi-gene assays, while prostate cancer biomarkers such as MyProstateScore 2.0 are expected to experience rapid adoption due to their non-invasive nature.
By biomolecule type, protein biomarkers held 50.41% market share in 2024, driven by established immunoassay integration in hospital workflows. Genetic biomarkers are advancing quickest at a 9.11% CAGR as high-plex sequencing becomes more affordable. Emerging RNA and methylation biomarkers further extend early detection windows and precision therapy alignment.
By profiling technology, omics platforms captured 33.58% revenue in 2024, offering comprehensive molecular characterization, while immunoassays grow at 8.96% CAGR with adoption of automation and microfluidic devices.
By end user, hospitals and clinics held a 43.44% share in 2024, though clinical and reference laboratories are growing fastest due to expertise in genomic data interpretation and economies of scale. Pharmaceutical partnerships for clinical trials and companion diagnostics also strengthen this segment.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/cancer-biomarkers-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
The market demonstrates regional variances reflecting cancer incidence and access to biomarker testing. Leading academic centers along the East and West Coasts spearhead diagnostic innovations, while access gaps persist in the Midwest and rural regions. Only 36.6% of the population lives within one hour of a National Cancer Institute-designated facility.
Seventeen states have enacted biomarker coverage mandates, boosting reimbursement rates and enabling broader clinical adoption. The Sun Belt states continue to lead revenue growth as older demographics show higher testing demand. Telehealth-enabled testing and at-home sample collection are expanding rural penetration, helped by broadband connectivity and public-health grants from the Cancer Moonshot initiative.
Market Dynamics
Market Drivers
Rising cancer incidence, aging demographics, and national precision medicine initiatives are accelerating biomarker adoption. Government funding programs and regulatory clarity have encouraged commercial development, while hospital systems are centralizing genomic laboratories for rapid turnaround testing.
Market Restraints
High diagnostic costs, payer variability, and multi-agency regulatory compliance remain key challenges hindering technology uptake, especially in rural or underinsured settings. Smaller labs struggle to absorb compliance costs under the FDA's updated LDT framework.
Market Opportunities
Emerging opportunities lie in AI-enabled multi-omic testing, liquid biopsy expansion, and modular assay systems that integrate genetic and protein biomarkers. Public-private funding partnerships continue to lower technology costs, broadening access to biomarker-based cancer care.
Purchase This Exclusive Report at Just USD 4583 Only: https://www.datamintelligence.com/buy-now-page?report=cancer-biomarkers-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ In-depth forecast of market size, CAGR, and segment-wise growth through 2030.
✔ Insights on regulatory shifts including FDA, CMS, and state-level coverage mandates.
✔ Segmentation analysis by disease type, biomolecule, technology, and end-user category.
✔ Evaluation of innovation trends such as AI, multi-omics, and liquid biopsy technologies.
✔ Profiles of leading US cancer biomarker companies and recent industry advancements.
Frequently Asked Questions (FAQs)
◆ How big is the United States cancer biomarkers market in 2025 and what is the forecast through 2030?
◆ Which cancer type contributes the largest share to the US biomarker market?
◆ What technologies are driving the growth of cancer biomarkers in the United States?
◆ Who are the leading players in the United States cancer biomarkers market?
◆ Which states and regions are driving the highest adoption rates of biomarker testing?
Company Insights
Abbott Laboratories Inc.
Thermo Fisher Scientific
Biomerieux
Illumina Inc.
F. Hoffmann-La Roche Ltd
Recent Developments:
June 2025: Mainz Biomed commenced the next phase of PancAlert blood test trials targeting early pancreatic cancer detection.
June 2025: Guardant Health received FDA Breakthrough Device designation for its Shield multi-cancer detection test with 98.6% specificity.
April 2025: Roche announced a USD 50 billion investment in US diagnostics and genetic therapy capacity expansion.
Conclusion
The United States cancer biomarkers market is on course for robust expansion through 2030, fueled by technological innovation, policy support, and precision medicine uptake. With liquid biopsy platforms improving patient experience and AI-powered analytics optimizing detection, cancer diagnostics are entering a more scalable and accessible era. Sustained investment from federal initiatives and public-private collaboration will continue to drive test adoption, reduce mortality disparities, and make biomarker-driven treatment an integral component of American oncology care.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Cancer Biomarkers Market to Surpass USD 11.2 Billion by 2030, Driven by Liquid Biopsies and AI-Enabled Diagnostics here
News-ID: 4220619 • Views: …
More Releases from DataM Intelligence 4Market Research LLP

US Frozen Food Market to Surpass USD 132.6 Billion by 2030 as Healthy, Convenien …
The US frozen food market, valued at USD 83.50 billion in 2024, is expected to reach USD 132.67 billion by 2030, growing at a CAGR of 8.1% from 2025 to 2030, according to DataM Intelligence. Growth in the segment is being propelled by shifting lifestyles, an increase in dual-income households, and the expanding popularity of ready-to-eat and ready-to-cook meals. Consumers are seeking quick, nutritious, and cost-effective food options that also…

US Agricultural Robots Market to Reach USD 8.6 Billion by 2033, Driven by Precis …
The United States agricultural robots market, valued at USD 3.1 billion in 2024, is projected to reach USD 8.6 billion by 2033, expanding at a CAGR of 11.43%, according to DataM Intelligence. This strong growth reflects the increasing adoption of robotics and automation technologies across US farmlands to mitigate labor shortages, improve productivity, and enable precision agriculture. Agricultural robots, also known as agri-bots, use GPS, AI, computer vision, and machine…

US Autonomous Vehicle Market Projected to Reach USD 307 Billion by 2033, Fueled …
The United States autonomous vehicle (AV) market is rapidly evolving, currently valued at USD 34.6 billion in 2024 and forecast to surge to approximately USD 307.1 billion by 2033, at a robust CAGR of 27.5%, according to DataM Intelligence. This growth is largely driven by technological breakthroughs, supportive government regulations, and increasing consumer acceptance of autonomous technologies. Autonomous vehicles-ranging from semi-autonomous systems with driver aids to fully autonomous self-driving cars-are…

US Warehouse Robotics Market to Reach USD 4.46 Billion by 2032, Driven by E-comm …
The United States warehouse robotics market, valued at USD 1.51 billion in 2024, is projected to reach USD 4.46 billion by 2032, expanding at a CAGR of 14.50% according to DataM Intelligence. Growth in the sector is driven by increasing automation demand across logistics, manufacturing, and e-commerce industries. As warehouses face mounting pressure from rising order volumes and labor shortages, autonomous mobile robots (AMRs), robotic arms, automated storage and retrieval…
More Releases for United
AI Image Recognition Market Will Hit Big Revenues In Future | Google (United Sta …
According to HTF Market Intelligence, the Global AI Image Recognition market to witness a CAGR of 13.42% during the forecast period (2024-2030). The Latest Released AI Image Recognition Market Research assesses the future growth potential of the AI Image Recognition market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify…
Movable Walls Market By Top Key Players- Hufcor (United States), Dormakaba (Swit …
Global Movable Walls Market Report from Advance Market Analytics (AMA) covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the electronic equipment market revenues, covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external…
Military Personal Protective Equipment Market 2024 | 3M Ceradyne (United States) …
Military personal protective equipment has become a crucial and standard element of soldier equipment. One of the major factor driving the market is the increasing role of ground troops in different parts of the world such as Iraq, Afghanistan and India among others. The demand for military personal protective equipment is anticipated to be driven by modernization initiatives undertaken by several large defense spenders globally and various internal security threats,…
Internet of Things Market 2021 | Google Inc. (United States), Cisco Systems Inc. …
The Internet of Things refers to the network of physical objects that attribute an IP address for Internet connectivity. Internet of Things is defined as an invisible and intelligent network of things that communicate indirectly or directly with each other. Internets of Things enable communication between the physical objects and other internet-enabled systems and devices. In addition, Internet of Things also makes the life of consumers much more comfortable and…
Logistics Market | Global Growing Industry Key Players - J.B. Hunt Transport Ser …
Market Research Reports Search Engine (MRRSE) has recently updated its massive research catalog by adding a new study, titled “Logistics Market”. The study offers a clear insight about the prevailing trends and innovations happening in the Logistics Market. Readers can further access details about research highlights and executive summary to gain a better idea about this assessment. The market overview covers key industry developments and market opportunity map during the…
Global Logistics Market 2024 | Key Players : J.B. Hunt Transport Services (Unite …
A fresh report has been added to the wide database of Market Research Report Search Engine (MRRSE). The research study is titled “Logistics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview.
Request for a sample of this research report @ https://www.mrrse.com/sample/2184
Logistics is…